International Journal of Clinical Oncology

Article	Citations
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment	110
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer	67
Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050	55
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)	50
Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis	47
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis	45
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma	41
The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study	37
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study	35
Aging, cancer, and antitumor immunity	29
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan	29
Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperi	28
Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1	27
Key promoters of tumor hallmarks	25
Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy	25
Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis	25
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy	24
The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan	24
Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma	24
Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma	24
Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System	23
Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy	22
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data	21
Frailty is associated with poor prognosis after resection for pancreatic cancer	20
The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases—a literature review	20

The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis	20
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)	20
Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer	20
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study	19
HER2-low breast cancer could be associated with an increased risk of brain metastasis	19
Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer	19
Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy	19
Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy	19
Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or	19
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma	18
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis	18
The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan	18
Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic	18
Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors	18
FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma	18
Serum LOX-1 is a novel prognostic biomarker of colorectal cancer	18
Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients	18
Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases	17
Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis	16
Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults af	16
An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma	16
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study	15
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study	15
Hereditary pancreatic cancer	15
TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway	15
Management and outcome of pediatric Wilms tumor with malignant inferior Vena cava thrombus: largest cohort of single-center experience	15
Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma	15
A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center	14
Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer	14
The prognostic role of prognostic nutritional index in nasopharyngeal carcinoma: A systematic review and meta-analysis	14
Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and meta-analysis	14
The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy	14
Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic	14
Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy	14
Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study	13
Soft-tissue sarcoma in adolescents and young adults	13
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer	13
The roles and limitations of bevacizumab in the treatment of ovarian cancer	13
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma	13
A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG	13
Association between chronic kidney disease and mortality in stage IV cancer	13
Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy	13
Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases	13
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary	13
Symptoms and signs of parotid tumors and their value for diagnosis and prognosis: a 20-year review at a single institution	13
Preoperative nutrition and exercise intervention in frailty patients with gastric cancer undergoing gastrectomy	13
Clinicopathological characteristics and prognosis of poorly cohesive cell subtype of gastric cancer	12
HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients	12
The usefulness of microRNA in urine and saliva as a biomarker of gastroenterological cancer	12
RETRACTED ARTICLE: Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma	12

Survival prediction and treatment strategies for patients with advanced laryngeal carcinoma: a population-based study	12
The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model	12
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium	12
Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer	12
Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis	12
LINC00943 is correlated with gastric cancer and regulates cancer cell proliferation and chemosensitivity via hsa-miR-101-3p	12
Urinalysis by combination of the dipstick test and urine protein–creatinine ratio (UPCR) assessment can prevent unnecessary lenvatinib interruption in patients with thyroid cancer	12
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1	12
Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study	11
Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in	11
SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis	11
Clinical and oncologic outcomes of laparoscopic versus open surgery in elderly patients with colorectal cancer: a retrospective multicenter study	11
Recent advances of the regulation roles of MicroRNA in glioblastoma	11
Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer	11
The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score	11
Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with	11
Lymphocyte–C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma	11
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retro	11
The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer	11
Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study	11
Jab1/Cops5: a promising target for cancer diagnosis and therapy	11
The role of surgery in the treatment of metastatic bone tumor	11
Dynamic prediction of cancer-specific survival for primary hypopharyngeal squamous cell carcinoma	11
Management of gastrointestinal perforation related to radiation	11
Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib	11
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib	11
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse	10
Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients	10
Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis	10
Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes	10
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA	10
Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study	10
Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study	10
Human cytomegalovirus protein UL136 activates the IL-6/STAT3 signal through MiR-138 and MiR-34c in gastric cancer cells	10
Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases	10
Central statistical monitoring of investigator-led clinical trials in oncology	10
Epidemiology and survival outcomes of primary gastrointestinal melanoma: a SEER-based population study	10
CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis	10
Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis	10
Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer	10
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2	10
Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis	10
Clinical characteristics and predictors of permanent stoma in rectal cancer patients underwent anterior resections: the value of preoperative prognostic nutritional index	10
The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway	10
Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining	9
Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer	9
Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021)	9
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis	9
Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience	9
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study	9
Preoperative predictors of dysphagia after transoral surgery	9
Pelvic reconstruction using an ice-cream cone prosthesis: correlation between the inserted length of the coned stem and surgical outcome	9
Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma	9
Long-term cognitive outcome in adult survivors of an early childhood posterior fossa brain tumour	9
Treatments for elderly cancer patients and reforms to social security systems in Japan	9
Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience	9
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study	9
A comparative examination of colorectal cancer burden in European Union, 1990–2019: Estimates from Global Burden of Disease 2019 Study	9
Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis	9
Neo-adjuvant chemotherapy alone for the locally advanced rectal cancer: a systematic review	9
Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan	9
Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study	9
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma	9
High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT	9
General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis	9
A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer	9
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis	9
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)	9
Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumab	8
Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location	8
Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review	8
Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer	8
Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan	8
Serum zinc deficiency in patients after gastrectomy for gastric cancer	8
Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex	8
Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketin	8
Artificial intelligence predicts lymph node metastasis or risk of lymph node metastasis in T1 colorectal cancer	8
Predicting short-term life expectancy of patients with end-stage gastric cancer using Onodera’s prognostic nutritional index	8
The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study	8
Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden	8

A novel clinically-oriented classification of fine-needle aspiration cytology for salivary gland tumors: a 20-year retrospective analysis of 1175 patients	8
Intra-corporeal robot-assisted versus open radical cystectomy: a propensity score-matched analysis comparing perioperative and long-term survival outcomes and recurrence patterns	8
Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib	8
Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs	8
Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients	8
APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients	8
Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer	8
Protective effect of the oral administration of cystine and theanine on oxaliplatin-induced peripheral neuropathy: a pilot randomized trial	7
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer	7
Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients	7
YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2	7
Prognostic significance of peritoneal cytology in low-risk endometrial cancer: comparison of laparoscopic surgery and laparotomy	7
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial	7
Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma	7
Preoperative iron status is a prognosis factor for stage II and III colorectal cancer	7
Oncologic outcomes for patients with endometrial cancer who received minimally invasive surgery: a retrospective observational study	7
Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer	7
Prognostic value of tumor deposits in locally advanced rectal cancer: a retrospective study with propensity score matching	7
Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis	7
Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 mutation	7
Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas	7
Utility of whole brain radiation therapy for leptomeningeal carcinomatosis	7
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801	7
Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective o	7
Role of the DEK oncogene in the development of squamous cell carcinoma	7
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study	7
Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer	7
Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis	7
Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospect	7
The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer	6
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?	6
Oncolytic virus combined with traditional treatment versus traditional treatment alone in patients with cancer: a meta-analysis	6
Hsa_circ_0003195 as a biomarker for diagnosis and prognosis of gastric cancer	6
4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study	6
Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy	6
Extreme leanness, lower skeletal muscle quality, and loss of muscle mass during treatment are predictors of poor prognosis in cervical cancer treated with concurrent chemoradiation therapy	6
Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression	6
Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan	6
Epidemiology and prognosis of lymphoepithelioma-like carcinoma: a comprehensive analysis of surveillance, epidemiology, and end results (SEER) database	6
Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study	6
Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial	6
Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analy	6
The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma	6
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab	6
An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors	6
Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents	6
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study	6
Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study	6
Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence	6
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study	6
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia	6
Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan	6
Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data	6
Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis	6
Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up	6
Relationship between psoas muscle index and long-term survival in older patients aged ≥ 80 years after endoscopic submucosal dissection for gastric cancer	6
Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, Japan	6
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis	6
Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma	6
Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer	6
Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis	6
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research	6
Adolescent and young adult brain tumors: current topics and review	6
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance	6
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048	6
Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy	6
Accuracy of histological grades from intraoperative frozen-section diagnoses of soft-tissue tumors	6
A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer	6
Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis	6
Contributions of HOTAIR polymorphisms to the susceptibility of cancer	6